VivePeptides logo

Research Use Only

Peptides for Libido and Sexual Health

Melanocortin-receptor research peptides studied in the context of central arousal and sexual-response pathways.

Peptides for Libido and Sexual Health are research compounds studied for their interactions with melanocortin receptor systems, particularly MC3R and MC4R pathways investigated in preclinical models of sexual arousal and desire. This category features PT-141 and Melanotan 2, two melanocortin receptor agonists with overlapping but distinct receptor binding profiles, supplied for laboratory research purposes only.

Reviewed by the VivePeptides Research DeskLast reviewed

Research Catalog

Compounds in this collection

PT-141 research peptide vial

PT-141

$65.00View
Melanotan 2 (MT2) research peptide vial

Melanotan 2 (MT2)

$50.00View

Research Overview

PT-141 and Melanotan 2: Melanocortin-Pathway Peptides for Preclinical Research

This research category encompasses melanocortin receptor-targeting peptides investigated for their roles in centrally mediated physiological signaling pathways. Preclinical interest in this area has grown because the melanocortin system, specifically the MC3 and MC4 receptor subtypes, appears to modulate neural circuits associated with arousal-related behavior in animal models.

VivePeptides supplies PT-141 (bremelanotide) and Melanotan 2 (MT2), both synthesized to high-purity standards with certificates of analysis available for every lot. PT-141 is a cyclic heptapeptide analog of alpha-MSH that functions as a melanocortin receptor agonist, with binding selectivity relevant to central nervous system signaling studies.

MT2 is a synthetic cyclic analog of alpha-MSH with a broader receptor binding profile that includes MC1R, making it of additional interest in pigmentation and metabolic research contexts. Both compounds are provided for in vitro and preclinical research use only and are not intended for human or veterinary use.

Melanocortin Receptor Selectivity Compared

PT-141 binds preferentially to MC3R and MC4R, while MT2 engages a broader profile that includes MC1R, allowing researchers to select the compound most appropriate for their receptor-specific study design. This distinction is a primary factor in compound selection for studies isolating arousal-related versus pigmentation-related melanocortin signaling.

Purity and Lot Documentation

Every batch of PT-141 and MT2 supplied by VivePeptides includes a certificate of analysis verifying peptide identity and purity, supporting reproducibility and documentation standards in preclinical research. Researchers can request lot-specific documentation to satisfy institutional and regulatory recordkeeping requirements.

Storage and Reconstitution Considerations

Both peptides require lyophilized storage at low temperature and protection from light to preserve stability prior to use. Researchers should follow validated reconstitution procedures, using an appropriate solvent and working concentration consistent with the study protocol, to maintain compound integrity across experimental timepoints.

Mechanism & Research Context

Mechanism Classes and Research Context for Libido-Related Peptide Studies

What distinguishes the compounds in this collection is the specificity of their melanocortin receptor binding profiles and the downstream signaling pathways each activates. PT-141 binds preferentially to MC3R and MC4R and has been investigated in rodent models for its effects on centrally mediated arousal-related behavior, with research noting that its mechanism proceeds independently of peripheral vascular pathways.

MT2 engages MC1R in addition to MC3R and MC4R, producing a broader activity profile relevant to researchers studying pigmentation, energy regulation, and arousal-related endpoints in parallel. Preclinical literature has examined dose-response relationships, receptor occupancy, and behavioral correlates in animal models for both compounds.

Researchers selecting between PT-141 and MT2 often consider the desired receptor selectivity, the study endpoint, and the need to isolate central versus peripheral signaling effects. Proper reconstitution, cold-chain storage, and validated handling protocols are essential to preserve peptide integrity across experimental timepoints.

Research FAQ

Frequently asked questions

What are libido peptides in the context of laboratory research?

In a research context, libido peptides are compounds such as PT-141 and Melanotan 2 that are studied for their interactions with melanocortin receptor pathways implicated in centrally mediated arousal-related signaling in preclinical models. These compounds act on MC3R and MC4R subtypes expressed in the central nervous system and are investigated for in vitro and animal model research purposes only, not for human therapeutic use.

What is PT-141 and how does it function in preclinical models?

PT-141 (bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist investigated in preclinical models for its activity at MC3R and MC4R, receptor subtypes implicated in centrally mediated behavioral signaling. Research literature has examined its receptor binding kinetics, downstream cAMP-coupled signaling effects, and behavioral correlates in rodent models, distinguishing its central mechanism from peripherally acting vasoactive compounds.

How does Melanotan 2 differ from PT-141 in preclinical studies?

Melanotan 2 (MT2) differs from PT-141 primarily in its receptor binding breadth, engaging MC1R in addition to MC3R and MC4R, which makes it relevant to studies examining both pigmentation signaling and arousal-related behavioral endpoints. Researchers selecting MT2 over PT-141 often do so when the study design requires examination of broader melanocortin system effects or side-by-side receptor subtype comparisons.

Are peptides studied for libido research the same as peptides investigated in ED models?

Peptides investigated in libido research contexts and those studied in preclinical models relevant to erectile function can overlap substantially, particularly compounds like PT-141 that act on central melanocortin receptors rather than through vascular or phosphodiesterase mechanisms. The distinction in study design typically centers on the specific behavioral or physiological endpoint being measured and the receptor pathway being isolated in the animal model.

What storage and handling conditions apply to PT-141 and Melanotan 2?

PT-141 and MT2 should be stored in lyophilized form at or below negative 20 degrees Celsius and protected from light and humidity to preserve peptide stability. Reconstitution should be performed under appropriate aseptic laboratory conditions using a compatible solvent, and reconstituted solutions should be aliquoted and stored according to validated protocols to prevent degradation across experimental timepoints.

Where can researchers source research-grade PT-141 and Melanotan 2 with verified purity?

VivePeptides supplies PT-141 and Melanotan 2 synthesized to research-grade purity standards, with certificates of analysis provided for each lot to support experimental reproducibility and institutional documentation requirements. Both compounds are available exclusively for in vitro and preclinical laboratory research use and are not intended for human or veterinary administration.

Related Research Collections

Continue exploring

Tanning PeptidesPeptides for Weight LossGLP-1 PeptidesPeptides for Fat Burning

All products are sold strictly for laboratory and scientific research use only. Not for human or animal consumption, diagnostic, or therapeutic use. Nothing on this page constitutes medical advice or a health claim.